Trial no.:
|
PACTR202212811501503 |
Date of Approval:
|
01/12/2022 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect of Transversus Abdominis Plane Block with Dexamethasone and Bupivacaine on Pain Relief Following Caesarean Delivery |
Official scientific title |
Effect of Perineural Dexamethasone on Ultrasound-Guided Transversus Abdominis Plane Block For Post Caesarean Analgesia At Korle-Bu Teaching Hospital |
Brief summary describing the background
and objectives of the trial
|
Caesarean delivery (CD) is a common surgical procedure with associated significant post-operative pain. Adequate post-caesarean analgesia enables the new mother to take care of the newborn while preventing the debilitating effects of uncontrolled post-operative pain. The most frequent negative response to caesarean delivery in Ghanaian women is pain. Analgesic options following CD in Korle-Bu Teaching Hospital include the use of intrathecal opioids (fentanyl), parenteral opioids (intramuscular pethidine), intravenous paracetamol and rectal diclofenac. The addition of the bilateral transversus abdominis plane (TAP) block with dexamethasone as an adjunct to the existing pain management modalities will provide adequate post-caesarean delivery analgesia and improve patient satisfaction.
AIM
The aim of this study is to assess the safety and effect on the duration of postoperative analgesia of perineural dexamethasone in ultrasound-guided bilateral TAP block in parturients who undergo caesarean delivery under spinal anaesthesia at Korle-Bu Teaching Hospital.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Bilateral transversus abdominis plane block with saline, bupivacaine and dexamethasone |
Anticipated trial start date |
01/03/2021 |
Actual trial start date |
31/05/2021 |
Anticipated date of last follow up |
30/07/2021 |
Actual Last follow-up date |
01/10/2021 |
Anticipated target sample size (number of participants) |
90 |
Actual target sample size (number of participants) |
99 |
Recruitment status |
Completed |
Publication URL |
|
|